Viridian Therapeutics REVEAL-2 Hits Phase 3 Endpoint, Shows “IV-like” Proptosis Gains in Chronic TED
Viridian Therapeutics (NASDAQ:VRDN) reported positive top-line results from REVEAL-2, a Phase 3 pivotal trial evaluating subcutaneous elegrobart (Ellay) in patients with chronic thyroid eye disease ...
An injectable monoclonal antibody that targets the insulin-like growth factor I receptor improved proptosis in more than half of people with chronic thyroid eye disease, according to topline results ...
This page lists all known medications that could potentially lead to 'Diplopia' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...
Please provide your email address to receive an email when new articles are posted on . Binocular diplopia was not an exceptional feature at GCA diagnosis. Diplopia resolution tends to be faster in ...
The list of possible causes of surgically induced postoperative diplopia is extensive. Retrobulbar and peribulbar injection have been reported to be associated with postoperative diplopia due to ...
With most previous studies on ocular myasthenia gravis stemming from investigations the neurology field, the present investigators came to their conclusion via neuro-ophthalmic analysis. In the ...
Acute-onset, constant diplopia with additional neurologic symptoms should be considered urgent until proven otherwise. A sudden onset of diplopia increases the likelihood that the central nervous ...
If you were the kid at school who wore an eye patch (or one of the kids who picked on them) then you will have come across amblyopia and strabismus. The first is better known as lazy eye and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results